BRIEF RESEARCH REPORT article
Front. Neurol.
Sec. Movement Disorders
Volume 16 - 2025 | doi: 10.3389/fneur.2025.1571718
Gender differences in prescribing patterns for patients with Parkinson's disease in Japan: a retrospective observational study using insurance claims databases
Provisionally accepted
- 1Department of Internal Medicine (Neurology), Keio University School of Medicine, Tokyo, Japan
- 2Japan Medical Office, Takeda Pharmaceutical Company Limited, Tokyo, Japan
Select one of your emails
You have multiple emails registered with Frontiers:
Notify me on publication
Please enter your email address:
If you already have an account, please login
You don't have a Frontiers account ? You can register here
Background: Parkinson’s disease (PD) is a neurodegenerative disorder, with increasing prevalence among aging populations. Gender differences in PD extend to symptom presentation and treatment response, suggesting the need for gender-specific management strategies.Methods: This gender-stratified analysis of a retrospective observational study used data from three nationwide Japanese healthcare databases. Patients aged ≥30 years diagnosed with PD between June 2016–May 2021 were included. Patient demographics, prescribing patterns, and levodopa dosages were analyzed descriptively. Results: Of 39,731 patients with PD identified, females (n = 22,724) outnumbered males (n = 17,007), especially in the ≥75 years group. Levodopa was the most commonly prescribed drug for both genders. The mean ± standard deviation maximum levodopa dose was numerically higher in males (520.0 ± 426.8 mg) compared with females (498.7 ± 424.2 mg). Usage of monoamine oxidase B inhibitors (MAOBI) was 24.0% in males and 18.9% in females. Among newly treated patients, >70% of both genders started treatment with levodopa monotherapy; a slightly higher proportion of males tended toward levodopa combination therapy. For both genders, concomitant drugs were most commonly MAOBI, non-ergot dopamine agonist, and zonisamide. However, females tended to receive a more diverse range of medications than these three drugs.Conclusion: This analysis highlights the high number of elderly female patients with PD in Japan. Slight gender differences in maximum levodopa dose and prescriptions for anti-PD drugs were observed. These findings emphasize the importance of personalized treatment approaches in PD management considering gender-specific differences in drug efficacy and side effects.
Keywords: Aged, Japan, Longitudinal Studies, Parkinson Disease, Practice patterns, Physicians', Sex Factors
Received: 05 Feb 2025; Accepted: 17 Jun 2025.
Copyright: © 2025 Seki, Kawata, Hayashi and Fujimoto. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
* Correspondence: Morinobu Seki, Department of Internal Medicine (Neurology), Keio University School of Medicine, Tokyo, Japan
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.